Gavin Corcoran
CIK: 0001745995
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Verrica Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 5, 2026VRCA
Verrica Pharmaceuticals Inc.
Award(A)DirectStock Option (right to buy)
16K shares- - Jun 5, 2025VRCA
Verrica Pharmaceuticals Inc.
Award(A)DirectStock Option (right to buy)
20K shares- - Mar 31, 2025VRCA
Verrica Pharmaceuticals Inc.
Award(A)DirectStock Option (right to buy)
17.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 | VRCA Verrica Pharmaceuticals Inc. | Award(A) Stock Option (right to buy) | 16,000 | - | - | Direct |
| Jun 5, 2025 | VRCA Verrica Pharmaceuticals Inc. | Award(A) Stock Option (right to buy) | 20,000 | - | - | Direct |
| Mar 31, 2025 | VRCA Verrica Pharmaceuticals Inc. | Award(A) Stock Option (right to buy) | 17,502 | - | - | Direct |
1-3 of 3 transactions
About Corcoran Gavin
Corcoran Gavin (SEC CIK 0001745995) files insider reports with the SEC as Director of Verrica Pharmaceuticals Inc. (VRCA).
Signal8 holds 4 ownership filings by Corcoran Gavin (1 Form 3, 3 Form 4), filed between Apr 2, 2025 and Jun 9, 2026. Those filings report 3 transactions, from Mar 31, 2025 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Corcoran Gavin's filings is in WEST CHESTER, PA.
Recent filings by Corcoran Gavin
Other insiders filing for Verrica Pharmaceuticals Inc. (VRCA)
- Zawitz David, Chief Operating Officer
- Rieger Jayson, CEO and President
- Rosenberg Noah L., CMO
- Kirby John J., Interim CFO
- Eichenfield Lawrence, Director
- Nguyen Diem, Director